NPCE logo

NeuroPace (NPCE) Company Overview

Profile

Full Name:

NeuroPace, Inc.

Sector:

Healthcare

Country:

United States

IPO:

April 22, 2021

Indexes:

Not included

Description:

NeuroPace is a medical technology company that develops innovative devices to treat neurological disorders, particularly epilepsy. Their main product, the RNS System, monitors brain activity and delivers targeted stimulation to prevent seizures, improving patients' quality of life and offering a new approach to epilepsy management.

Key Details

Price

$13.77

Annual Revenue

$65.42 M(+43.72% YoY)

Annual EPS

-$1.27(+33.51% YoY)

Annual ROE

-118.91%

Beta

1.57

Events Calendar

Earnings

Next earnings date:

Mar 5, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 Wells Fargo
Overweight
Jan 21, 25 UBS
Buy
Dec 17, 24 JP Morgan
Overweight
Nov 13, 24 Wells Fargo
Overweight
Aug 14, 24 Wells Fargo
Overweight
Aug 14, 24 Cantor Fitzgerald
Overweight
Jul 15, 24 Morgan Stanley
Equal-Weight
May 9, 24 Cantor Fitzgerald
Overweight
Mar 14, 24 Wells Fargo
Overweight
Mar 12, 24 JP Morgan
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for NeuroPace?
  • Does NeuroPace pay dividends?
  • What sector is NeuroPace in?
  • What industry is NeuroPace in?
  • What country is NeuroPace based in?
  • When did NeuroPace go public?
  • Is NeuroPace in the S&P 500?
  • Is NeuroPace in the NASDAQ 100?
  • Is NeuroPace in the Dow Jones?
  • When was NeuroPace's last earnings report?
  • When does NeuroPace report earnings?
  • Should I buy NeuroPace stock now?

What is the ticker symbol for NeuroPace?

The ticker symbol for NeuroPace is NASDAQ:NPCE

Does NeuroPace pay dividends?

No, NeuroPace does not pay dividends

What sector is NeuroPace in?

NeuroPace is in the Healthcare sector

What industry is NeuroPace in?

NeuroPace is in the Medical Devices industry

What country is NeuroPace based in?

NeuroPace is headquartered in United States

When did NeuroPace go public?

NeuroPace's initial public offering (IPO) was on April 22, 2021

Is NeuroPace in the S&P 500?

No, NeuroPace is not included in the S&P 500 index

Is NeuroPace in the NASDAQ 100?

No, NeuroPace is not included in the NASDAQ 100 index

Is NeuroPace in the Dow Jones?

No, NeuroPace is not included in the Dow Jones index

When was NeuroPace's last earnings report?

NeuroPace's most recent earnings report was on Nov 12, 2024

When does NeuroPace report earnings?

The next expected earnings date for NeuroPace is Mar 5, 2025

Should I buy NeuroPace stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions